Journal article
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.
- Abstract:
-
This paper in the series from the World Congress of Gastroenterology addresses the safety and immunogenicity of biological therapy. The safety profile in randomized controlled studies of all biological agents in Crohn's disease (CD) and ulcerative colitis has been generally favorable, but a small percentage of patients experience severe side effects on biological therapy, including pneumonia, tuberculosis, lymphoma, demyelination, drug-induced lupus, or hepatotoxicity. Although there is unequ...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- American journal of gastroenterology
- Volume:
- 106
- Issue:
- 9
- Pages:
- 1594-1603
- Publication date:
- 2011-09-01
- DOI:
- EISSN:
-
1572-0241
- ISSN:
-
0002-9270
- Source identifiers:
-
353561
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:353561
- UUID:
-
uuid:3bed5228-a9ac-4a8a-b68d-4ef6395ef0a9
- Local pid:
- pubs:353561
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2011
If you are the owner of this record, you can report an update to it here: Report update to this record